Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-11-14
2008-11-25
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S130100
Reexamination Certificate
active
07456153
ABSTRACT:
Modulating agents and methods for enhancing or inhibiting classical cadherin-mediated functions are provided. The modulating agents comprise at least a tryptophan-containing cell adhesion recognition sequence of a classical cadherin molecule, a conservative analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a cell adhesion recognition sequence. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, pharmaceutically active substance and/or support material.
REFERENCES:
patent: 5245012 (1993-09-01), Lombari et al.
patent: 5417224 (1995-05-01), Petrus et al.
patent: 5505956 (1996-04-01), Kim et al.
patent: 5510628 (1996-04-01), Georger, Jr. et al.
patent: 5613958 (1997-03-01), Kochinke et al.
patent: 6031072 (2000-02-01), Blaschuk et al.
patent: 6110747 (2000-08-01), Blaschuk et al.
patent: 6169071 (2001-01-01), Blaschuk et al.
patent: 6203788 (2001-03-01), Blaschuk et al.
patent: 6207639 (2001-03-01), Blaschuk et al.
patent: 6248864 (2001-06-01), Blaschuk et al.
patent: 6277824 (2001-08-01), Doherty et al.
patent: 6294153 (2001-09-01), Modi
patent: 6303576 (2001-10-01), Blaschuk et al.
patent: 6310177 (2001-10-01), Blaschuk et al.
patent: 6326352 (2001-12-01), Blaschuk et al.
patent: 6333307 (2001-12-01), Blaschuk et al.
patent: 6346512 (2002-02-01), Blaschuk et al.
patent: 6358920 (2002-03-01), Blaschuk et al.
patent: 6391855 (2002-05-01), Blaschuk et al.
patent: 6417325 (2002-07-01), Blaschuk et al.
patent: 6433149 (2002-08-01), Blaschuk et al.
patent: 6465427 (2002-10-01), Blaschuk et al.
patent: 6472367 (2002-10-01), Blaschuk et al.
patent: 6472368 (2002-10-01), Doherty et al.
patent: 6562786 (2003-05-01), Blaschuk et al.
patent: 0 566 816 (1993-10-01), None
patent: 0 821 060 (1998-01-01), None
patent: WO91/18098 (1991-11-01), None
patent: WO00/20607 (2000-04-01), None
Avrahami et al., Biochemistry, 40(42) 12591-603, 2001.
Goldman et al., FEMS Microbiology Letters, 183(2), 2090214, 2000.
Al-Obeidi, F., et al., “Peptide and Peptidomimetic Libraries,”Molecular Biotechnology9(3):205-223, Jun. 1998.
Avellana-Adalid, V., et al., “Expansion of Rat Oligodendrocyte Progenitors Into Proliferative “Oligospheres” That Retain Differentiation Potential,”J. Neurosci. Res. 45:558-570, 1996.
Baron-Van Evercooren, A., et al., “Cell-Cell Interactions During the Migration of Myelin-Forming Cells Transplanted in the Demyelinated Spinal Cord,”GLIA16:147-164, 1996.
Blaschuk, O., et al., “Cadherins as modulators of angiogenesis and the structural integrity of blood vessels,”Cancer and Metastasis Reviews19:1-5, 2000.
Blaschuk, O., et al., “Estradiol Stimulates Cadherin Expression in Rat Granulosa Cells,”Developmental Biology136:564-567, 1989.
Blaschuk, O., et al., “Identification of a Cadherin Cell Adhesion Recognition Sequence,”Developmental Biology139:227-229, 1990.
Blaschuk, O., et al., “Identification of a Conserved Region Common to Cadherins and Influenza Strain A Hemagglutinins,”J. Mol. Biol. 211:679-682, 1990.
Cardarelli, P., et al., “The Collagen Receptor α2β1, from MG-63 and HT1080 Cells, Interacts with a Cyclic RGD Peptide,”J. Biol. Chem. 267(32):23159-23164, 1992.
Cepek, K., et al., “Expression of a candidate cadherin in T lymphocytes,”Proc. Natl. Acad. Sci. USA93:6567-6571, 1996.
Doherty, P., et al., “Signal transduction events underlying neurite outgrowth stimulated by cell adhesion molecules,”Curr. Op. Neurobiol4:49-55, 1994.
Doherty, P., et al., “The Neural Cell Adhesion Molecule and Synaptic Plasticity,”J. Neurobiology26(3):437-446, 1995.
Doherty, P., et al., “CAM-FGF Receptor Interactions: A Model for Axonal Growth,”Mol. Cell. Neurosci. 8:99-111, 1996.
Eichler, J., et al., “Peptide, Peptidomimetic, and Organic Synthetic Combinatorial Libraries,”Medicinal Research Review15(6):481-496, Nov. 1995.
Fannon, A., et al., “A Model for Central Synaptic Junctional Complex Formation Based on the Differential Adhesive Specificities of the Cadherins,”Neuron17:423-434, 1996.
Franz, T., “The Finite Dose Technique as a Valid in vitro Model for the Study of Percutaneous Absorption in Man,”Curr. Prob. Dermatol. 7:58-68, 1978.
Franz, J., “Percutaneous Absorption. On the Relevance of In Vitro Data,”The Journal of Invest. Dermatol. 64:190-195, 1975.
Gillespie, P., et al., “Conformational Analysis of Dipeptide Mimetics,”Peptide Science43(3):191-217, 1997.
Groves, A.K., et al., “Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells,”Nature362:453-455, 1993.
Guilford, “E-Cadherin Downregulation in Cancer: Fuel on the Fire?”Molecular Medicine Today5(4):172:177, Apr. 1999 (XP001155310 ISSN:1357-4310).
Hall, H., et al., “Review: A Role for the FGF Receptor in the Axonal Growth Response Stimulated by Cell Adhesion Molecules?”Cell Adhesion and Communication3:441-450, 1996.
Hruby, V., et al., “Synthesis of oligopeptide and peptidomimetic libraries,”Current Opinion in Chemical Biology1:114-119, 1997.
Iruela-Arispe et al., “Expression of SPARC during Development of the Chicken Chorioallantoic Membrane: Evidence for Regulated Proteolysis In Vivo,”Molecular Biology of the Cell6:327-343, 1995.
Jankowski, J.A.Z., et al., “Alterations in Classical Cadherins Associated with Progreession in Ulcerative and Crohn's Colitis,”Laboratory Investigation78(9):1155-1167, Sep. 1998.
Laird, W., et al., “Gap Junction Turnover, Intracellular Trafficking, and Phosphorylation Of Connexin43 in Brefeldin A-treated Rat Mammary Tumor Cells,”J. Cell Biol. 131(5):1193-1203, Dec. 1995.
Lee, M-G., et al., “Expression of the Homotypic Adhesion Molecule E-Cadherin by Immature Murine Thymocytes and Thymic Epithelial Cells1,”J. Immunol. 152:5653-5659, 1994.
Li, G., et al., “N-Cadherin-mediated Intercellular Interactions Promote Survival and Migration of Melanoma Cells,”Cancer Research, Amer. Assoc. for Cancer Research61(9):3819-3825, May 1, 2001.
Martin, K., et al., “Cell Adhesion Molecules, CREB, and the Formation of New Synaptic Connections,”Neuron17:567-570, 1996.
Martin-Padura, I., et al., “Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration,”J. Cell. Biol. 142(1):117-127, 1998.
Munro, S., et al., “Characterization of Cadherins Expressed by Murine Thymocytes,”Cellular Immunology169:309-312, 1996.
Munro, S., et al.,Cell Adhesion and Invasion in Cancer Metastasis, RG Landes Co., Austin, TX, 1996, Chap. 3, “The Structure, Function and Regulation of Cadherins,” pp. 17-34.
Newton, S., et al., “N-Cadherin Mediates Sertoli Cell-Spermatogenic Cell Adhesion,”Develop. Dynamics197:1-13, 1993.
Noë et al., “Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides,”Journal of Cell Science112(1):127-135, Jan. 1999.
Nollett et al, “Phylogenetic Analysis of the Cadherin Superfamily allows Identification of Six Major Subfamilies Besides Several Solitary Members,”Journal of Molecular Biology299:551-572, 2000.
Overduin, M., et al., “Solution Structure of the Epithelial Cadherin Domain Responsible for Selective Cell Adhesion,”Science267:386-389, Jan. 20, 1995.
Purohit, S., et al., “Impaired E-cadherin expression in human spermatozoa in a male factor infertility subset signifies E-cadherin-mediated adhesion mechanisms operative in sperm-oolemma interactions,”Biochemical and Biophysical Communications316:903-909, 2004.
Ripka, A., et al., “P
Blaschuk Orest W.
Michaud Stephanie D.
Adherex Technologies Inc.
Seed IP Law Group PLLC
Tate Christopher R.
Teller Roy
LandOfFree
Compounds and methods for modulating functions of classical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for modulating functions of classical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for modulating functions of classical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4042004